Two separate groups have published new research comparing early AVR with clinical surveillance for the treatment of asymptomatic severe aortic stenosis. Overall, the two groups found, early treatment was associated with multiple benefits—and no added risk of harm.

If U.S. healthcare is to help advance responsible and ethical AI for all communities, it very much needs to continue prioritizing DEI initiatives. 

The people who can least afford healthcare are often among those who need healthcare the most. 

One of the cardiologists involved in the procedures said they represent "a significant leap forward in structural heart intervention."

The new Self-Centering Guide Catheter was designed to help care teams with the retrograde crossing of the aortic valve during TAVR. Researchers evaluated the safety and effectiveness of the catheter, sharing their experience in JACC: Cardiovascular Interventions.

Medical device companies navigating regulatory pathways should know: Large language models are not reliable guides. 

Almost one in three healthcare organizations allow their people to use AI without formal restrictions. 

Philips is recalling all sizes of its Tack Endovascular System after 20 patient injuries were reported. Interventional cardiologists are urged to stop using the device immediately.